[{"data":1,"prerenderedAt":252},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates:0":3},{"blogPost":4,"otherBlogs":83},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":25,"categories":27,"tags":29,"class_list":30,"featured_media_src_url":38,"_links":39},697,"2026-07-10T06:36:34",{"rendered":8},"https://wp.ncikenya.go.ke/?p=697","kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates","publish","post","https://wp.ncikenya.go.ke/2026/07/10/kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates/",{"rendered":14},"Kenya Records 35,867 New Cancer Cases in Latest GLOBOCAN 2024 Estimates",{"rendered":16,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Nairobi, Kenya – The latest Global Cancer Observatory (GLOBOCAN) 2024 estimates indicate that 35,867 new cancer cases are diagnosed annually in Kenya, while 22,888 people die from the disease each year. The report also estimates that 76,165 people are living with cancer within five years of diagnosis. Compared to the GLOBOCAN 2022 estimates, the 2024 report reflects lower estimated numbers of new cancer cases, cancer-related deaths, and five-year prevalence. However, cancer remains a significant public health challenge, stressing the need for sustained investment in prevention, early detection, diagnosis, treatment, research, and palliative care.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>According to the report, breast cancer remains the most commonly diagnosed cancer in Kenya, accounting for 5,822 new cases (16.2%), followed by cervical cancer with 4,294 cases (12.0%), prostate cancer with 3,601 cases (10.0%), oesophageal cancer with 2,532 cases (7.1%), and colorectal cancer with 2,525 cases (7.0%).\u003C/strong>\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"439\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png\" alt=\"\" class=\"wp-image-699\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-300x129.png 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-768x330.png 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1536x659.png 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1.png 1871w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The report also highlights the leading causes of cancer-related deaths. Breast cancer remains the leading cause of cancer mortality, claiming 2,882 lives annually, followed by cervical cancer (2,606 deaths), oesophageal cancer (2,353 deaths), prostate cancer (2,199 deaths), and colorectal cancer (1,481 deaths).\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Among men, prostate cancer continues to be the most commonly diagnosed cancer, accounting for 3,601 new cases (25.9%), followed by oesophageal, colorectal, stomach, and leukaemia. Among women, breast cancer remains the leading cancer with 5,822 new cases (26.5%), followed by cervical cancer, colorectal cancer, oesophageal cancer, and ovarian cancer.\u003C/strong>\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"495\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1024x495.png\" alt=\"\" class=\"wp-image-698\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1024x495.png 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-300x145.png 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-768x371.png 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1536x742.png 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2.png 1674w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The findings reaffirm the urgent need to strengthen Kenya’s cancer control efforts through enhanced public awareness, timely screening, early diagnosis, equitable access to quality treatment, palliative care, and sustained investment in cancer research. Early detection remains one of the most effective strategies for improving survival rates and reducing cancer-related deaths.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) continues to coordinate the implementation of the National Cancer Control Strategy 2023–2027, which provides a comprehensive framework for reducing the country’s cancer burden through five strategic pillars: cancer prevention and early detection; diagnosis, treatment and palliative care; governance and financing; cancer registration, surveillance and research; and monitoring, evaluation, and strategic information.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>While Kenya has made significant progress in expanding access to cancer services, strengthening county cancer programmes, improving cancer surveillance, and fostering strategic partnerships, the latest GLOBOCAN estimates demonstrate that cancer remains a major public health challenge requiring increased investment and a whole-of-society response.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>NCI-K calls upon all Kenyans to prioritize healthy lifestyles, participate in recommended cancer screening programmes, seek medical attention promptly for persistent symptoms, and support national efforts aimed at reducing the burden of cancer. The Institute also urges continued collaboration among government, county governments, healthcare providers, development partners, academia, the private sector, and communities to accelerate progress towards a future where fewer Kenyans are diagnosed with cancer and more survive the disease.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The GLOBOCAN 2024 estimates, published by the International Agency for Research on Cancer (IARC), provide the latest global and country-specific cancer incidence and mortality statistics and serve as an important resource for informing cancer control planning, policy development, and resource allocation.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",false,{"rendered":19,"protected":17},"\u003Cp>Nairobi, Kenya – The latest Global Cancer Observatory (GLOBOCAN) 2024 estimates indicate that 35,867 new cancer cases are diagnosed annually in Kenya, while 22,888 people die from the disease each year. The report also estimates that 76,165 people are living with cancer within five years of diagnosis. Compared to the GLOBOCAN 2022 estimates, the 2024 […]\u003C/p>\n",1,699,"open","","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":23,"footnotes":23},[],[28],4,[],[31,11,32,33,34,35,36,37],"post-697","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-updates","https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png",{"self":40,"collection":46,"about":49,"author":52,"replies":56,"version-history":59,"predecessor-version":62,"wp:featuredmedia":66,"wp:attachment":69,"wp:term":72,"curies":79},[41],{"href":42,"targetHints":43},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697",{"allow":44},[45],"GET",[47],{"href":48},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[50],{"href":51},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[53],{"embeddable":54,"href":55},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[57],{"embeddable":54,"href":58},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=697",[60],{"count":20,"href":61},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697/revisions",[63],{"id":64,"href":65},700,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697/revisions/700",[67],{"embeddable":54,"href":68},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/699",[70],{"href":71},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=697",[73,76],{"taxonomy":74,"embeddable":54,"href":75},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=697",{"taxonomy":77,"embeddable":54,"href":78},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=697",[80],{"name":81,"href":82,"templated":54},"wp","https://api.w.org/{rel}",[84,141,194],{"id":85,"date":86,"date_gmt":86,"guid":87,"modified":89,"modified_gmt":89,"slug":90,"status":10,"type":11,"link":91,"title":92,"content":94,"excerpt":96,"author":20,"featured_media":98,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":99,"categories":101,"tags":102,"class_list":103,"featured_media_src_url":105,"_links":106},721,"2026-09-25T17:34:12",{"rendered":88},"https://wp.ncikenya.go.ke/?p=721","2026-09-27T07:03:42","kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care","https://wp.ncikenya.go.ke/2026/09/25/kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care/",{"rendered":93},"Kenya’s Efforts to Advance Cancer Prevention, Screening, Early Detection and Access to Care.",{"rendered":95,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>25\u003Csup>th\u003C/sup> September, 2026 – Hong Kong, China\u003C/strong> — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation, \u003Cstrong>“Kenya’s Efforts on Cancer Prevention, Screening, Early Detection and Access to Care,”\u003C/strong> highlighted the country’s efforts to build a coordinated and equitable national cancer-control system, while drawing lessons that may be relevant to other low- and middle-income countries.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg\" alt=\"\" class=\"wp-image-730\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-225x300.jpg 225w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522.jpg 960w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Emily Barsito Presenting on Kenya’s  Efforts on Cancer Prevention, Screening, Early Detection and Access to Care\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Cancer Prevention through Governance and Policy\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s response to the growing cancer burden is anchored in the \u003Cstrong>Cancer Prevention and Control Act, 2012\u003C/strong>, which established the National Cancer Institute of Kenya (NCI-K) to spearhead and coordinate cancer prevention and control nationally.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through NCI-K and a multisectoral approach, Kenya continues to strengthen leadership and coordination in cancer prevention and control, public information, education and awareness, and implementation of the National Cancer Control Strategy.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Investing in Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Prevention remains a key pillar of Kenya’s cancer-control efforts.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Public information, education and awareness initiatives are being used to increase knowledge about cancer risk factors, prevention and the importance of screening, while creating demand for early detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has also strengthened tobacco control as an important public-health intervention, including restrictions on smoking in public spaces to reduce population exposure to tobacco smoke.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>HPV Vaccination and Cervical Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya continues to advance efforts towards the elimination of cervical cancer through HPV vaccination.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">More than \u003Cstrong>four million girls aged 9–14 years\u003C/strong> have been vaccinated through school-based programmes and integration of HPV vaccination into primary healthcare.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This investment in prevention is critical to reducing the future burden of cervical cancer and protecting generations of Kenyan women.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Bringing Screening Closer to Communities\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has integrated cancer screening with \u003Cstrong>primary healthcare (PHC)\u003C/strong> to improve access to preventive and early-detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The country has also embraced innovative and culturally appropriate approaches to screening and awareness, including reaching underserved and hard-to-reach populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Integrating cancer prevention and screening into primary healthcare provides an opportunity to bring services closer to communities and strengthen early detection across the country.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Early Detection and Diagnosis\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Early diagnosis remains essential to improving cancer outcomes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has invested in advanced oncology and diagnostic technologies, including \u003Cstrong>CT, MRI and PET-CT\u003C/strong>, to strengthen diagnosis, staging and treatment planning.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These investments support the country’s ambition to shift cancer diagnosis from predominantly \u003Cstrong>Stage III and IV disease towards Stage I and II\u003C/strong>, when treatment can be more effective and outcomes improved.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Decentralising Cancer Care\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Access to quality cancer care is being strengthened through the decentralisation of oncology services and the establishment of \u003Cstrong>regional cancer centres\u003C/strong> capable of providing comprehensive cancer treatment.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This approach is helping reduce geographical disparities and bringing specialised cancer services closer to patients and their families.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Sustainable health financing is equally important. Kenya’s \u003Cstrong>Universal Health Coverage (UHC)\u003C/strong> agenda and the \u003Cstrong>Social Health Insurance Fund (SHIF)\u003C/strong> oncology package are intended to reduce the financial burden associated with cancer treatment and protect families from catastrophic health expenditure.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Using Cancer Data to Guide Action\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable data is fundamental to effective cancer prevention and control.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s \u003Cstrong>National Cancer Registry\u003C/strong> provides critical information to support evidence-based policy, planning, resource allocation, research and evaluation of cancer-control interventions.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Without reliable data, countries risk making decisions without a clear understanding of where the burden lies, who is affected and where resources are most needed.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Lessons for other Low- and Middle-Income Countries\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience offers several lessons that may be relevant to other countries facing similar challenges:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>1. Good governance is essential.\u003C/strong>\u003Cbr>Strong leadership, coordination and accountability provide the backbone for resilient cancer-control systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>2. Prevention is the best investment.\u003C/strong>\u003Cbr>Countries should prioritise preventing cancers wherever effective prevention interventions are available.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>3. Decentralise cancer care.\u003C/strong>\u003Cbr>Bringing services closer to communities can reduce geographical and socioeconomic inequalities in access to care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>4. Integrate cancer services with primary healthcare.\u003C/strong>\u003Cbr>Integration provides a practical pathway for expanding prevention, awareness and screening services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>5. Invest in sustainable health financing.\u003C/strong>\u003Cbr>Cancer care should be accessible to those who need it, not only to those who can afford it.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>6. Build reliable cancer information systems.\u003C/strong>\u003Cbr>Cancer data is the lifeblood of effective planning, resource allocation and programme evaluation. Without it, decision-making remains largely blind.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>7. Leverage innovation to advance equity.\u003C/strong>\u003Cbr>Technology and innovation should be deliberately deployed to expand access, improve quality and address the needs of underserved populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>A shared commitment to cancer control\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience demonstrates that progress in cancer control requires more than investment in treatment alone. It requires \u003Cstrong>strong governance, prevention, early detection, accessible screening, reliable data, sustainable financing, innovation and equitable access to care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As countries work towards reducing the growing global cancer burden, sharing experiences and learning from one another can help accelerate progress—particularly in low- and middle-income settings.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya remains committed to strengthening its cancer-control systems and advancing equitable access to prevention, early detection and quality cancer care for all.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>#NCIK #HealthGovernance #CancerPreventionAndControlAct #PublicHealthPolicy #CancerControl #CancerPrevention #CancerScreening #EarlyDetection #UniversalHealthCoverage\u003C/strong>\u003C/p>\n",{"rendered":97,"protected":17},"\u003Cp>25th September, 2026 – Hong Kong, China — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care. The presentation, “Kenya’s Efforts on Cancer Prevention, Screening, […]\u003C/p>\n",734,{"pagelayer_contact_templates":100,"_pagelayer_content":23,"footnotes":23},[],[28],[],[104,11,32,33,34,35,36,37],"post-721","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734523-768x1024.jpg",{"self":107,"collection":112,"about":114,"author":116,"replies":118,"version-history":121,"predecessor-version":124,"wp:featuredmedia":128,"wp:attachment":131,"wp:term":134,"curies":139},[108],{"href":109,"targetHints":110},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721",{"allow":111},[45],[113],{"href":48},[115],{"href":51},[117],{"embeddable":54,"href":55},[119],{"embeddable":54,"href":120},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=721",[122],{"count":28,"href":123},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions",[125],{"id":126,"href":127},735,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions/735",[129],{"embeddable":54,"href":130},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/734",[132],{"href":133},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=721",[135,137],{"taxonomy":74,"embeddable":54,"href":136},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=721",{"taxonomy":77,"embeddable":54,"href":138},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=721",[140],{"name":81,"href":82,"templated":54},{"id":142,"date":143,"date_gmt":143,"guid":144,"modified":143,"modified_gmt":143,"slug":146,"status":10,"type":11,"link":147,"title":148,"content":150,"excerpt":152,"author":20,"featured_media":153,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":154,"categories":156,"tags":157,"class_list":158,"featured_media_src_url":161,"_links":162},750,"2026-10-18T12:58:40",{"rendered":145},"https://wp.ncikenya.go.ke/?p=750","the-national-cancer-institute-of-kenya-citizens-service-delivery-charter","https://wp.ncikenya.go.ke/2026/10/18/the-national-cancer-institute-of-kenya-citizens-service-delivery-charter/",{"rendered":149},"The National Cancer Institute of Kenya Citizen’s Service Delivery Charter.",{"rendered":151,"protected":17},"\n\u003Cdiv data-wp-interactive=\"core/file\" class=\"wp-block-file\">\u003Cobject data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/NCI-KENYA-SERVICE-DELIVERY-CHARTER-26.pdf\" type=\"application/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of NCI-KENYA-SERVICE-DELIVERY-CHARTER 26.\">\u003C/object>\u003Ca id=\"wp-block-file--media-05b0a8d9-80dc-454f-b910-4e15d23d4541\" href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/NCI-KENYA-SERVICE-DELIVERY-CHARTER-26.pdf\">NCI-KENYA-SERVICE-DELIVERY-CHARTER 26\u003C/a>\u003Ca href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/NCI-KENYA-SERVICE-DELIVERY-CHARTER-26.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-05b0a8d9-80dc-454f-b910-4e15d23d4541\">Download\u003C/a>\u003C/div>\n",{"rendered":23,"protected":17},0,{"pagelayer_contact_templates":155,"_pagelayer_content":23,"footnotes":23},[],[20],[],[159,11,32,33,34,36,160],"post-750","category-uncategorized",null,{"self":163,"collection":168,"about":170,"author":172,"replies":174,"version-history":177,"predecessor-version":180,"wp:attachment":184,"wp:term":187,"curies":192},[164],{"href":165,"targetHints":166},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/750",{"allow":167},[45],[169],{"href":48},[171],{"href":51},[173],{"embeddable":54,"href":55},[175],{"embeddable":54,"href":176},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=750",[178],{"count":20,"href":179},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/750/revisions",[181],{"id":182,"href":183},752,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/750/revisions/752",[185],{"href":186},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=750",[188,190],{"taxonomy":74,"embeddable":54,"href":189},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=750",{"taxonomy":77,"embeddable":54,"href":191},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=750",[193],{"name":81,"href":82,"templated":54},{"id":195,"date":196,"date_gmt":196,"guid":197,"modified":196,"modified_gmt":196,"slug":199,"status":10,"type":11,"link":200,"title":201,"content":203,"excerpt":205,"author":20,"featured_media":207,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":208,"categories":210,"tags":212,"class_list":213,"featured_media_src_url":216,"_links":217},736,"2026-10-06T18:27:09",{"rendered":198},"https://wp.ncikenya.go.ke/?p=736","nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services","https://wp.ncikenya.go.ke/2026/10/06/nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services/",{"rendered":202},"NCI-K Hosts AMPATH Flow Cytometry Team to Strengthen Cancer Diagnostic Services.",{"rendered":204,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized laboratory technologies, including flow cytometry, which plays an important role in the diagnosis and management of several cancers, particularly haematological malignancies.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Key areas discussed included:\u003C/p>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Recognition of flow cytometry as an essential specialized cancer diagnostic service.\u003C/li>\n\n\n\n\u003Cli>Adoption of panel-based reimbursement rather than individual antibody-based reimbursement.\u003C/li>\n\n\n\n\u003Cli>Appropriate reimbursement for immunohistochemistry (IHC) panels.\u003C/li>\n\n\n\n\u003Cli>Development of national technical and quality standards for specialized cancer diagnostics.\u003C/li>\n\n\n\n\u003Cli>Establishment of coordinated specimen-referral pathways.\u003C/li>\n\n\n\n\u003Cli>Recognition of qualified reference laboratories to support testing, training and quality assurance.\u003C/li>\n\u003C/ul>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The AMPATH delegation included Dr. Teresa Lotodo, Lead Pathologist and Chair, Pathology Department, Moi University & Medical Director, Flow Cytometry Laboratory; Raphael Koima, AFCP Program Manager/Coordinator; Dr. Gilbert Olbara, Lead Clinician and Head of Paediatric Oncology, MTRH; Dr. Ronald Tonui, Director, AMPATH Reference Laboratory; and Nicholas Kigen, Lead Laboratory Scientist, ARL.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting reaffirmed the importance of strategic partnerships, innovation and strengthened diagnostic capacity in improving early and accurate cancer diagnosis and ultimately advancing Kenya’s cancer response.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K remains committed to building partnerships that strengthen cancer prevention, diagnosis, treatment and care towards a cancer-free nation.\u003C/p>\n",{"rendered":206,"protected":17},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor. The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized […]\u003C/p>\n",737,{"pagelayer_contact_templates":209,"_pagelayer_content":23,"footnotes":23},[],[28,211],43,[],[214,11,32,33,34,35,36,37,215],"post-736","category-partnerships","https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/DSC_5500.JPG-1024x683.jpeg",{"self":218,"collection":223,"about":225,"author":227,"replies":229,"version-history":232,"predecessor-version":235,"wp:featuredmedia":239,"wp:attachment":242,"wp:term":245,"curies":250},[219],{"href":220,"targetHints":221},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736",{"allow":222},[45],[224],{"href":48},[226],{"href":51},[228],{"embeddable":54,"href":55},[230],{"embeddable":54,"href":231},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=736",[233],{"count":20,"href":234},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736/revisions",[236],{"id":237,"href":238},738,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736/revisions/738",[240],{"embeddable":54,"href":241},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/737",[243],{"href":244},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=736",[246,248],{"taxonomy":74,"embeddable":54,"href":247},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=736",{"taxonomy":77,"embeddable":54,"href":249},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=736",[251],{"name":81,"href":82,"templated":54},1792766192165]